| CYTK Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CYTK shares outstanding history going back to 6/25/2013:
Also see: CYTK Market Cap History CYTK YTD Return |
CYTK Shares Outstanding History — Cytokinetics Share Count Over Time
As of 5/4/2026 Cytokinetics has 124.43 million CYTK shares outstanding. Investors often track the CYTK shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CYTK share count trends over time, with 53 historical shares outstanding datapoints presented, dating back to 6/25/2013.
| CYTK Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CYTK Historical Shares Outstanding: +13.37% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CYTK Stock Price Chart |
| About Cytokinetics Inc |
| Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. Co. specializes in muscle biology and the mechanics of muscle performance. It is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility. Its cardiac muscle contractility program is focused on the cardiac sarcomere. We show 53 historical shares outstanding datapoints in our coverage of CYTK's shares outstanding history. Understanding the changing numbers of CYTK shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CYTK versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CYTK by allowing them to research CYTK shares outstanding history as well as any other stock in our coverage universe. |
| CYTK Current Stock Quote |
Quotes delayed 20 minutes  Free CYTK Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CYTK Share Performance |
| Shares Outstanding Peers |
| Cytokinetics (CYTK) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CYTR Shares Outstanding History CYTX Shares Outstanding History DARE Shares Outstanding History DAWN Shares Outstanding History DBTX Shares Outstanding History DCGO Shares Outstanding History DCOY Shares Outstanding History DCPH Shares Outstanding History DCTH Shares Outstanding History DEPO Shares Outstanding History More Healthcare companies » |
CYTK Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
